title: Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis.
abstract: Pulmonary colonization and infection of patients with cystic fibrosis by Mycobacterium spp. has recently been recognized as a potentially important clinical problem. However, frequent contamination of mycobacterial cultures by pseudomonads has hampered efforts to define the extent of this problem. This study was done to evaluate current techniques and to establish a more efficient method of recovering mycobacteria from respiratory secretions of patients with cystic fibrosis. Decontamination of respiratory specimens (n = 121) with 0.25% N-acetyl-L-cysteine and 1% sodium hydroxide (NALC-NaOH) was associated with a high rate of pseudomonas overgrowth for both Lowenstein-Jensen slants (74%) and BacTec vials supplemented with PANTA (polymyxin B [50 U/ml], amphotericin B [5 micrograms/ml], nalidixic acid [20 micrograms/ml], trimethoprim [5 micrograms/ml], azlocillin [10 micrograms/ml]) (36%). This overgrowth limited recovery of mycobacteria to only 64% (9 of 14) of specimens positive by smear for acid-fast bacilli (AFB). Decontamination of specimens (n = 441) with NALC-NaOH, followed by 5% oxalic acid treatment, resulted in contamination of only 5% of Lowenstein-Jensen slants and 3% of BacTec vials. AFB were recovered from all 90 AFB smear-positive specimens following the use of this decontamination technique. We recommend that respiratory secretions be decontaminated with NALC-NaOH and oxalic acid to decrease the incidence of Pseudomonas aeruginosa overgrowth.
authors: Clinical Microbiology Immunology Laboratories, University of North Carolina Hospitals, Chapel Hill.
authors: S
authors: S
authors: Whittier
authors: R L
authors: RL
authors: Hopfer
authors: M R
authors: MR
authors: Knowles
authors: P H
authors: PH
authors: Gilligan
mesh_terms: D000111:Acetylcysteine; D001431:Bacteriological Techniques; D003550:Cystic Fibrosis / Q000382:microbiology*; D005069:Evaluation Studies as Topic; D006801:Humans; D008168:Lung / Q000382:microbiology; D009161:Mycobacterium / Q000187:drug effects / Q000302:isolation & purification*; D010070:Oxalates; D019815:Oxalic Acid; D011549:Pseudomonas / Q000254:growth & development / Q000302:isolation & purification; D012137:Respiratory System / Q000382:microbiology*; D012972:Sodium Hydroxide; D013183:Sputum / Q000382:microbiology; D014132:Trachea / Q000382:microbiology
chemical_list: D010070:Oxalates; D012972:Sodium Hydroxide; D019815:Oxalic Acid; D000111:Acetylcysteine